Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 21,751,284 | 21,751,284 | 0 | $1.09B | $956.40M | 26.81% | -$136.16M |
| Revolution Medicines, Inc.(RVMD) | 5,981,212 | 5,981,212 | 0 | $192.77M | $232.13M | 6.51% | +$39.36M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,161,801 | 0 | $207.50M | $154.08M | 4.32% | -$53.42M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,428,613 | 3,186,376 | +757,763 | $105.28M | $151.86M | 4.26% | +$46.58M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 4,370,024 | 4,370,024 | 0 | $109.78M | $149.41M | 4.19% | +$39.64M |
| GH Research PLC(GHRS) | 10,400,158 | 10,400,158 | 0 | $110.87M | $121.27M | 3.40% | +$10.40M |
| Protagonist Therapeutics Inc | 3,755,990 | 3,319,290 | -436,700 | $108.66M | $115.01M | 3.22% | +$6.35M |
| Cullinan Therapeutics, Inc.(CGEM) | 3,196,701 | 5,750,683 | +2,553,982 | $54.47M | $100.29M | 2.81% | +$45.82M |
| Olema Pharmaceuticals, Inc.(OLMA) | 9,135,893 | 9,135,893 | 0 | $103.42M | $98.85M | 2.77% | -$4.57M |
| Structure Therapeutics IncADS | 812,988 | 2,487,762 | +1,674,774 | $34.84M | $97.69M | 2.74% | +$62.85M |
| Xoma Corp Del | 3,633,743 | 3,633,743 | 0 | $87.39M | $86.08M | 2.41% | -$1.31M |
| Kura Oncology, Inc.(KURA) | 4,786,293 | 4,082,037 | -704,256 | $102.09M | $84.05M | 2.36% | -$18.04M |
| 4d Molecular Therapeutics In | 3,922,413 | 3,922,413 | 0 | $124.97M | $82.33M | 2.31% | -$42.64M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 955,000 | +955,000 | $0 | $76.88M | 2.15% | +$76.88M |
| CG Oncology, Inc.(CGON) | 1,884,191 | 2,417,885 | +533,694 | $82.72M | $76.33M | 2.14% | -$6.38M |
| Merus N V | 1,172,249 | 1,279,049 | +106,800 | $52.79M | $75.68M | 2.12% | +$22.89M |
| AC Immune SASHS(ACIU) | 14,571,236 | 18,834,936 | +4,263,700 | $43.13M | $75.15M | 2.11% | +$32.02M |
| Tyra Biosciences, Inc.(TYRA) | 4,661,194 | 4,661,194 | 0 | $76.44M | $74.53M | 2.09% | -$1.91M |
| 89bio Inc | 4,047,354 | 7,568,479 | +3,521,125 | $47.11M | $60.62M | 1.70% | +$13.51M |
| Celcuity Inc.(CELC) | 0 | 3,466,000 | +3,466,000 | $0 | $56.77M | 1.59% | +$56.77M |
| Third Harmonic Bio Inc | 4,365,933 | 4,365,933 | 0 | $41.21M | $56.76M | 1.59% | +$15.54M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 1,190,107 | +1,190,107 | $0 | $51.32M | 1.44% | +$51.32M |
| Zymeworks Inc.(ZYME) | 5,870,000 | 5,870,000 | 0 | $61.75M | $49.95M | 1.40% | -$11.80M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $74.28M | $46.02M | 1.29% | -$28.26M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,162,306 | 1,162,306 | 0 | $51.00M | $40.81M | 1.14% | -$10.19M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,863,809 | 1,569,422 | -294,387 | $60.01M | $38.89M | 1.09% | -$21.12M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $50.19M | $34.30M | 0.96% | -$15.89M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $48.67M | $34.10M | 0.96% | -$14.57M |
| Foghorn Therapeutics Inc.(FHTX) | 0 | 5,302,000 | +5,302,000 | $0 | $30.49M | 0.85% | +$30.49M |
| Calliditas Therapeutics AbADS | 750,000 | 750,000 | 0 | $16.24M | $29.24M | 0.82% | +$13.01M |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,521,948 | 1,521,948 | 0 | $35.99M | $29.24M | 0.82% | -$6.76M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,742,409 | 2,742,409 | 0 | $28.90M | $28.99M | 0.81% | +$82.3K |
| Engene Holdings Inc COM | 2,251,037 | 2,251,037 | 0 | $38.16M | $21.23M | 0.59% | -$16.93M |
| Janux Therapeutics, Inc.(JANX) | 2,919,818 | 441,528 | -2,478,290 | $109.93M | $18.50M | 0.52% | -$91.44M |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 2,989,474 | 0 | $23.74M | $17.49M | 0.49% | -$6.25M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 4,326,710 | 6,293,282 | +1,966,572 | $8.91M | $16.61M | 0.47% | +$7.70M |
| Allakos Inc | 16,552,417 | 16,552,417 | 0 | $20.86M | $16.55M | 0.46% | -$4.30M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,902,972 | 0 | $11.75M | $9.88M | 0.28% | -$1.87M |
| Ikena Oncology Inc | 4,769,164 | 4,769,164 | 0 | $6.77M | $7.87M | 0.22% | +$1.10M |
| Vigil Neuroscience Inc | 1,813,633 | 1,813,633 | 0 | $6.18M | $7.25M | 0.20% | +$1.07M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,000,000 | 2,000,000 | 0 | $10.56M | $6.96M | 0.20% | -$3.60M |
| CytomX Therapeutics, Inc.(CTMX) | 6,595,801 | 5,228,461 | -1,367,340 | $14.38M | $6.38M | 0.18% | -$8.00M |
| Elevation Oncology Inc | 2,312,200 | 2,312,200 | 0 | $11.86M | $6.24M | 0.17% | -$5.62M |
| Verastem, Inc.(VSTM) | 1,685,219 | 1,685,219 | 0 | $19.89M | $5.02M | 0.14% | -$14.86M |
| Cidara Therapeutics Inc | 0 | 343,055 | +343,055 | $0 | $4.10M | 0.11% | +$4.10M |
| Verve Therapeutics Inc | 650,000 | 650,000 | 0 | $8.63M | $3.17M | 0.09% | -$5.46M |
| Molecular Partners AGADS(MOLN) | 443,221 | 443,221 | 0 | $1.72M | $3.17M | 0.09% | +$1.45M |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 3,853,818 | 0 | $11.75M | $2.96M | 0.08% | -$8.79M |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 917,826 | 0 | $4.17M | $2.85M | 0.08% | -$1.32M |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $28.63M | $2.69M | 0.08% | -$25.95M |
| Pieris Pharmaceuticals Inc | 0 | 257,626 | +257,626 | $0 | $2.55M | 0.07% | +$2.55M |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $2.48M | $2.02M | 0.06% | -$459.6K |
| Viracta Therapeutics Inc | 3,614,662 | 3,614,662 | 0 | $3.69M | $1.97M | 0.06% | -$1.72M |
| Forte Biosciences Inc | 2,982,105 | 2,982,105 | 0 | $2.09M | $1.60M | 0.04% | -$488.2K |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $4.92M | $1.31M | 0.04% | -$3.60M |
| Nls Pharmaceutics LtdSHS | 5,747,126 | 5,747,126 | 0 | $1.04M | $1.25M | 0.03% | +$201.7K |
| Unicycive Therapeutics Inc | 3,611,601 | 2,200,000 | -1,411,601 | $4.98M | $1.10M | 0.03% | -$3.88M |
| Rezolute, Inc.(RZLT) | 190,815 | 190,815 | 0 | $486.6K | $820.5K | 0.02% | +$333.9K |
| Molecular Templates Inc | 522,238 | 522,238 | 0 | $1.17M | $600.6K | 0.02% | -$569.2K |
| Aslan Pharmaceuticals LtdADS | 1,049,999 | 1,049,999 | 0 | $646.0K | $315.0K | 0.01% | -$331.0K |
| An2 Therapeutics Inc | 1,239,470 | 0 | -1,239,470 | $4.03M | $0 | — | -$4.03M |
| Cidara Therapeutics Inc | 6,861,127 | 0 | -6,861,127 | $6.31M | $0 | — | -$6.31M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 361,406 | 0 | -361,406 | $643.3K | $0 | — | -$643.3K |
| Delcath Systems, Inc.(DCTH) | 1,202,067 | 0 | -1,202,067 | $5.73M | $0 | — | -$5.73M |
| Kronos Bio Inc | 2,905,043 | 0 | -2,905,043 | $3.78M | $0 | — | -$3.78M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 1,686,924 | 0 | -1,686,924 | $4.05M | $0 | — | -$4.05M |
| Pieris Pharmaceuticals Inc | 20,609,863 | 0 | -20,609,863 | $3.78M | $0 | — | -$3.78M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,875,000 | 0 | -1,875,000 | $44.63M | $0 | — | -$44.63M |